This inventor holds 1 USPTO granted patent. Top assignees: Dainippon Sumitomo Pharma Co., Ltd., Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 140 
1 out of 834,659 Years Active: 2010
Title: The Innovations of Hideyuki Ikeda
Introduction
Hideyuki Ikeda is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of tumor antigen proteins. His work has implications for cancer treatment and immunotherapy.
Latest Patents
Ikeda holds a patent for a tumor antigen protein and its use as an inducer of cytotoxic T cells. The patent describes a protein that comprises the same or substantially the same amino acid sequence as that shown in SEQ ID NO: 2, or a peptide derived from this protein. This innovation is crucial for advancing cancer therapies.
Career Highlights
Throughout his career, Hideyuki Ikeda has worked with Dainippon Sumitomo Pharma Co., Ltd., a leading pharmaceutical company in Japan. His experience in this organization has allowed him to contribute to significant advancements in medical science.
Collaborations
Ikeda has collaborated with several professionals in his field, including Noriyuki Sato and Tomohide Tsukahara. These partnerships have fostered innovation and development in cancer research.
Conclusion
Hideyuki Ikeda's contributions to biotechnology and cancer treatment through his patent and collaborations highlight his importance as an inventor. His work continues to influence the field and offers hope for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile